Recombinant <i>Dermatophagoides farinae </i>type 2 allergen protein and its preparation method and application
11236137 · 2022-02-01
Assignee
Inventors
Cpc classification
C07K1/34
CHEMISTRY; METALLURGY
C07K1/36
CHEMISTRY; METALLURGY
C12N2800/22
CHEMISTRY; METALLURGY
International classification
Abstract
Provided are an optimized Der f2 gene, a recombinant Der f2 protein encoded thereby, a vector comprising said gene, and a Pichia pastoris strain. Also provided are an expression method, a purification method, and an application of the recombinant Der f2 protein.
Claims
1. A DNA sequence encoding a Der f2 protein, wherein said DNA sequence has a base sequence as shown in SEQ ID NO: 1.
2. A vector comprising the DNA sequence of claim 1.
3. A host cell comprising the vector of claim 2, wherein said host cell is a Pichia pastoris strain.
4. A method for expressing a recombinant Der f2 protein, comprising the steps of: (a) constructing a vector comprising said DNA sequence encoding a Der f2 protein of claim 1; (b) linearizing the vector of step A, transferring it into a Pichia pastoris strain, and culturing under a suitable condition; and (c) recovering a Der f2 fermentation broth and purifying the recombinant Der f2 protein.
5. A method for purifying a recombinant Der f2 protein, comprising the steps of: (a) filtering, through a 0.45 μm filter membrane, an ultrafiltered supernatant, wherein the supernatant is obtained by centrifuging the Der f2 fermentation broth in claim 4 at a low temperature and a high speed before ultrafiltration against a 50 mM sodium acetate buffer at pH 4.0; (b) passing the Der f2 fermentation broth pretreated in step (a) through a chromatographic separation column pre-equilibrated with a first equilibration buffer comprising 50 mM sodium acetate at pH 4.0, and eluting with a gradient of a first elution buffer to collect a Der f2 protein elution peak, wherein the elution buffer comprises 50 mM sodium acetate and 1.0 M sodium chloride at pH 4.0; (c) loading the Der f2 protein elution peak collected in step (b) and subsequently ultrafiltered with a 20 mM phosphate solution at pH 6.0, on an anion chromatographic column, and collecting a Der f2 flow-through peak, wherein the anion chromatographic column is pre-equilibrated with a second equilibration buffer comprising 20 mM phosphate at pH 6.0; and (d) adding ammonium sulfate to the Der f2 flow-through peak collected in step (c) to the final concentration of 1.5 M, pH 6.0 to obtain a Der f2 sample, before loading the Der f2 sample to a hydrophobic chromatographic column pre-equilibrated with a third equilibration buffer comprising 1.5 M ammonium sulfate and 20 mM phosphate at pH 6.0, and eluting with a gradient of a second elution buffer comprising 20 mM phosphate at pH 6.0, thereby purifying the recombinant Der f2 protein.
6. The vector of claim 2, wherein said vector is pAO815, pPIC9, pPIC9K, pPIC3.5, pPIC3.5K, pPICZ A, B, C or pGAPZ A, B, C.
7. The host cell of claim 3, wherein the Pichia pastoris strain is SMD1168, GS115, KM71, X33 or KM71H.
8. The host cell of claim 7, wherein there is a 242 bp interval between the DNA sequence encoding the Der f2 protein and ATG of AOX1 on Pichia pastoris; and the DNA sequence encoding the Der f2 protein is preceded by Kozak sequence GCCACCATGG (SEQ ID NO: 10).
Description
BRIEF DESCRIPTION OF THE DRAWINGS
(1)
(2) The sequence before optimization corresponds to the nucleotide sequence of the natural Der f2 gene; the sequence after optimization corresponds to the nucleotide sequence of the recombinant Der f2 gene of the present invention, that is, the codon-optimized sequence.
(3)
(4)
(5)
(6)
(7)
(8)
(9)
(10) Lane 1 represents 500 bp DNA ladder; lane 2 represents a PCR product of the recombinant Der f2 gene containing EcoRI and XhoI restriction sites at both ends.
(11)
(12)
(13)
(14)
(15)
(16)
(17)
(18)
(19)
(20)
(21)
(22)
(23)
(24)
(25)
(26)
(27)
(28)
(29)
(30)
(31)
(32)
(33)
(34)
(35)
(36)
DETAILED DESCRIPTION OF THE INVENTION
(37) The invention is further illustrated below in conjunction with specific examples. It should be understood that the examples referred to are merely illustrative of the invention and are not intended to limit the scope of the present invention.
Example 1 Codon Optimization of Recombinant Der f2
(38) Based on the DNA sequence of Der f2 disclosed in GenBank (GenBank accession no. EF139432.1), as shown in SEQ ID No: 2, the inventors performed codon optimization of the gene to obtain the Der f2 gene of the present invention of which the nucleotide sequence is as shown in SEQ ID No: 1 and the amino acid sequence is as shown in SEQ ID No: 3. Comparison of each parameter before and after codon optimization of the Der f2 is as follows:
(39) 1. Codon Adaptation Index (CAI)
(40) As can be seen from
(41) 2. Optimal Codon Usage Frequency (FOP)
(42) As can be seen from
(43) 3. GC Base Content (GC Curve)
(44) The ideal distribution region of GC content is 30%-70%, and any peak outside this region will affect transcription and translation efficiency to varying degrees. As can be seen from the comparison of the average GC base content distribution region plots of the Der f2 gene in
Example 2: Construction of an Expression Plasmid Containing the Der f2 Gene
(45) A sequence of EcoRI restriction site was introduced at the 5′ end, and a sequence of XhoI restriction site was introduced at the 3′ end of the codon-optimized Der f2, and then full gene synthesis was performed. The synthesized gene fragment was constructed into the pUC57 plasmid supplied by GenScript (Nanjing) Co., Ltd., thereby obtaining a plasmid for long-term preservation, denoted as pUC57-Der f2 plasmid.
(46) PCR amplification was performed using the pUC57-Der f2 plasmid as a template, and primers of following sequences:
(47) TABLE-US-00001 upstream primer (SEQ ID No: 4): M13 F: TGT AAA ACG ACG GCC AGT downstream primer (SEQ ID No: 5): M13 R: CAG GAA ACA GCT ATG AC
(48) The total volume of the reaction was 50 μL, in which 2.5 μL of each primer at a concentration of 10 μmon was added, 1 μL of dNTP at a concentration of 10 mmol/L was added, and 0.5 μL DNA polymerase being Q5 (#M0491L, purchased from New England BioLabs) at 2 U/μL was added. The reaction conditions were 98° C. for 5 seconds, 55° C. for 45 seconds, and 72° C. for 30 seconds. After 25 cycles, the product was analyzed by 1.0% agarose gel electrophoresis. The results showed that the product size was consistent with the expected size (results as shown in
Example 3: Construction of a Pichia pastoris Host Engineering Strain Containing a Recombinant Der f2 Gene
(49) Formulation of YPDS solid medium: the medium was formulated according to the instructions of Easy SelectPichia Expression Kit, Invitrogen, comprising 10 g/L yeast extract, 20 g/L peptone, 20 g/L glucose, 15 g/L agarose, and 182 g/L sorbitol.
(50) Electrocompetent cells were prepared according to the method of instructions of Easy SelectPichia Expression Kit, Invitrogen. The plasmid pPICZ-Der f2 obtained in Example 2 was linearized with Sac I restriction endonuclease (#R0156S, purchased from New England Biolabs), and precipitated with ethanol. The linearized vector was electrotransformed into competent cells of Pichia pastoris X33. The cells were plated on YPDS solid media and cultured at 30° C. until the transformants grew.
Example 4: Inducible Expression and Identification of Engineering Strains Containing Codon-Optimized Der f2 Gene
(51) Formulation of BMGY medium: the medium was formulated according to the instructions of Easy SelectPichia Expression Kit, Invitrogen, comprising 10 g/L yeast extract, 20 g/L peptone, 3 g/L K.sub.2HPO.sub.4, 11.8 g/L KH.sub.2PO.sub.4, 13.4 g/L YNB, 4×10.sup.−4 g/L biotin, and 10 g/L glycerin.
(52) Formulation of BMMY medium: the medium was formulated according to the instructions of Easy SelectPichia Expression Kit, Invitrogen, comprising 10 g/L yeast extract, 20 g/L peptone, 3 g/L K.sub.2HPO.sub.4, 11.8 g/L KH.sub.2PO.sub.4, 13.4 g/L YNB, 4×10.sup.−4 g/L biotin, and 5 mL/L methanol.
(53) Methanol-Induced Expression of an Engineering Strain of Codon-Optimized Der f2
(54) The host monoclonal engineering strain obtained in Example 3 was picked into a 5 mL BMGY medium and cultured in a 50 mL sterile centrifuge tube at 30° C. and 220 rpm until OD.sub.600 reaches 1.0-2.0. 1 mL of the culture was stored, and the remaining strain solution was resuspended and transferred to BMMY for induced expression at a small scale, and methanol was supplemented every 24 hours to a final concentration of 1%. One week later, the supernatant of the strain solution was collected by centrifugation, and analyzed by SDS-PAGE gel electrophoresis and Western blotting. Brightness of expressed product bands was observed.
Example 5: Purification of Recombinant Der f2 Protein
(55) The Der f2 constructed in this invention is obtained mainly by ion exchange and hydrophobic chromatography purification methods. HiTrap SP FF, HiTrap Q FF, and HiTrap Phenyl HP were selected as the chromatographic packings. The specific steps are as follows:
(56) 1. Pretreatment of the Fermentation Broth by Impurity Removal
(57) The fermentation broth of host engineering strain containing Der f2 obtained according to Example 4 was centrifuged at a low temperature at 12000 rpm for 15 minutes to collect a supernatant, and the supernatant was ultrafiltrated against a 50 mM sodium acetate buffer at pH 4.0, and filtered through a 0.45 μm filter membrane to obtain a supernatant of the treated fermentation broth.
(58) 2. Cation Exchange Chromatography
(59) The treated fermentation broth of the previous step was loaded on a SPFF cation exchange chromatographic column, wherein the equilibration buffer was 50 mM NaAc at pH 4.0, the elution buffer was 50 mM NaAc and 1.0 M NaCl at pH 4.0, isocratic elution was performed at 12%, 25% and 100%, and the sample peaks were mainly concentrated at the 25% elution peak.
(60) 3. Anion Exchange Chromatography
(61) The Der f2 protein peak purified in the previous step was collected, and the sample was ultrafiltrated with a 20 mM NaH.sub.2PO.sub.4 solution at pH 6.0, and loaded on a HiTrap Q FF chromatography packing. The equilibration buffer was 20 mM NaH.sub.2PO.sub.4 at pH 6.0, and the elution buffer was 20 mM NaH.sub.2PO.sub.4 and 1.0 M NaCl at pH 6.0. The flow-through peak of Der f2 was collected.
(62) 4. Hydrophobic Chromatography
(63) The flow-through peak of Der f2 from the anion chromatography was collected, and ammonium sulfate was added to a final concentration of 1.5 M. The fermentation broth supernatant treated as above was loaded on a Phenyl HP chromatographic column. The equilibration buffer was 20 mM NaH.sub.2PO.sub.4 and 1.5 M (NH.sub.4).sub.2SO.sub.4 at pH 6.0; the elution buffer was 20 mM NaH.sub.2PO.sub.4 at pH 6.0, isocratic elution was performed at 25%, 50%, 70%, and 100%, and the Der f2 protein is mainly concentrated at the 75% elution peak.
Example 6: Sequence Analysis of N-Terminal Amino Acids of Protein
(64) The determination of N-terminal sequence of proteins and polypeptides is one of the important links in the quality control of pharmaceutical industry. In this experiment, N-terminal sequence analysis based on classical Edman degradation method was used.
(65) The N-terminal sequence of Der f2 protein purified from Example 5 was analyzed by Shimadzu Automatic Protein Peptide Sequencing Instrument (PPSQ-33A, SHIMADZU). The results showed in
Example 7: Analysis of Der f2 Protein Activity
(66) The purified Der f2 protein was dialyzed against a PBS buffer at pH 7.4, and the protein concentration was determined by a BCA protein concentration assay kit (Cat No: 23225, purchased from Pierce), and fold-diluted to 250 ng, 125 ng, 62.5 ng, 31.25 ng, and 15.625 ng. the obtained solution was detected for the reactivity with sera of patients allergic to Dermatophagoides farinae by comparing with natural Der f2.
Example 8: Determination of Gene Copy Number of Recombinant Der f2 Engineering Strain
(67) 1. Inoculation X33 strain: the strains were cultured in YPD media for 24 h, the X33 genome was extracted by a genomic extraction kit (purchased from Tiangen Biotech (Beijing) Co., Ltd.), and GAP gene was amplified using the X33 genome as a template, and GAP-1 and GAP-2 as primers of which the sequences are as follows:
(68) TABLE-US-00002 upstream primer (SEQ ID No: 6) GAP-1: GGTATTAACGGTTTCGGACGTATTG downstream primer (SEQ ID No: 7) GAP-2: GATGTTGACAGGGTCTCTCTCTTGG
(69) The total volume of the reaction was 50 μL, in which 2.5 μL of each primer at a concentration of 10 μmon was added, 1 μL of dNTP at a concentration of 10 mmol/L was added, and 0.5 μL DNA polymerase being Taq DNA Polymerase (M0267S, purchased from New England BioLabs) at 2 U/μL was added. The reaction conditions were 94° C. for 10 minutes, 94° C. for 30 seconds, 55° C. for 30 seconds, 68° C. for 30 seconds, and 68° C. for 5 minutes. After 30 cycles, the product was analyzed by 1.0% agarose gel electrophoresis. The results showed that the product size was consistent with the expected size (400 bp) (results as shown in
(70) 2. The Der f2 gene was amplified using the pPICZ-Der f2 plasmid of Example 2 as a template, and 5′ AOX and 3′ AOX as primers with the following sequences:
(71) TABLE-US-00003 upstream primer (SEQ ID No: 8): 5′ AOX: GACTGGTTCCAATTGACAAGC downstream primer (SEQ ID No: 9): 3′ AOX: GGCAAATGGCATTCTGACAT
(72) The total volume of the reaction was 50 μL, in which 2.5 μL of each primer at a concentration of 10 μmon was added, 1 μL of dNTP at a concentration of 10 mmol/L was added, and 0.5 μL DNA polymerase being Taq DNA Polymerase (#M0267S, purchased from New England BioLabs) at 2 U/μL was added. The reaction conditions were 94° C. for 10 minutes, 94° C. for 30 seconds, 49° C. for 30 seconds, and 68° C. for 60 seconds, and 68° C. for 5 minutes. After 30 cycles, the product was analyzed by 1.0% agarose gel electrophoresis. The results showed that the product size was consistent with the expected size (750 bp) (results as shown in
(73) 3. Calculation of Gene Copy Number:
(74) The concentration (ng/μL) of the standard plasmid was determined by a nucleic acid microanalyzer (Nanodrop2000, ThermoFisher). Copy numbers of GAP and Der f2 were calculated according to the following formula:
Copies/u=(60.02×10.sup.23)×(ng/μl×10.sup.−9)/(DNA length×660)
4. Processing Samples to be Tested
(75) The pPICZ-Der f2-X33 engineering strain was inoculated in YPD liquid media at 30° C. overnight; and the genome was extracted the next day, and its concentration (ng/μL) and purity were determined by a nucleic acid quantitative microanalyzer.
(76) 5. Establishment of a Standard Curve
(77) The standard plasmids of T-GAP and T-Der f2 with known copy numbers were gradiently diluted to 10.sup.8, 10.sup.7, 10.sup.6, 10.sup.5, 10.sup.4, and 10.sup.3 copies/μ1, respectively. The fluorescent quantitative PCR were performed using GAP-1 and GAP-2, 5′ AOX and 3′ AOX as primers, respectively.
(78) 6. Determination of Copy Number of Der f2 Gene in Recombinant Strains
(79) The genome sample of extracted pPICZ-Der f2-X33 was serially 10-fold-diluted to obtain four gradients of stock solution, 10.sup.−1, 10.sup.−2, and 10.sup.−3. Fluorescent quantitative PCR was performed using GAP-1 and GAP-2, 5′ AOX and 3′ AOX as primers, and each gradient was assayed three times.
(80) TABLE-US-00004 TABLE 1 Results of copy number of Der f2 in the genome detected by real-time fluorescent quantitative PCR Average Ct value gene copy number (10.sup.N)Copy number of Der f2 gene in Pichia pastoris genome Copy number of the Der f2 gene/copy DNA GAP Der f2 GAP Der f2 number of the concentration gene gene gene gene GAP gene Stock 19.86 22.96 6.31 5.88 6.42 solution 10.sup.−1 22.14 24.48 5.95 5.72 5.97 10.sup.−2 23.44 24.53 5.72 5.47 5.58 10.sup.−3 29.07 24.73 3.46 5.47 5.95
Example 9: Analysis of the Acting Elements in the Der f2 Genome
(81) There is no stable additional plasmid in Pichia pastoris, the expression vector is homologously recombined with the host chromosome, and the exogenous gene expression framework is fully integrated into the chromosome to realize the expression of the exogenous gene; the typical Pichia pastoris expression vector contains a regulatory sequence of alcohol oxidase gene, and contains the main structures comprising AOX promoter, multiple cloning site, transcription termination and polyA formation gene sequence (TT), screening markers and the like. The promoter is a cis-element for gene expression regulation and an important element for the genetically engineered expression vector. The important role of the promoter at the transcriptional level determines the gene expression level.
(82) The Der f2 genome was extracted according to the method of Example 8, and the Der f2 gene was amplified from the genome using 5′ AOX and 3′ AOX as primers according to the method in Step 2 of Example 8. The obtained samples were sent to GenScript (Nanjing) Co., Ltd. to detect the acting element before and after the Der f2 gene which was inserted into the genome. The results of genome sequencing indicated that the Der f2 gene expression framework was integrated into the chromosome of Pichia pastoris by a single cross-insertion, which enabled the Der f2 gene to express the gene using the AOX promoter on the yeast chromosome, and thus the expression level was higher.
(83) Generally, the closer the first ATG of the exogenous coding sequence to the ATG of AOX1, the better the expression effect. In the gene construction, the inventors chose an enzyme cleavage site closest to the ATG of AOX1, and found that the Der f2 gene was away from ATG of AOX1 only by 242 bp. In addition, Kozak sequence GCCACCATGG (SEQ ID No: 10) was added in front of Der f2 gene, which can greatly improve transcription and translation efficiency and increase expression efficiency of Der f2 gene in eukaryotes.